We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Target Set on Cancer Gene MCL1

Broad Institute and Dana-Farber colleagues identify several chemical compounds that tamp down the expression of the MCL1 gene.
News

e-Therapeutics’ Preliminary Results for the Year Ended 31 January 2012

Further drugs for infection and depression expected to enter trials in 2012.
News

Cytheris Appoints Damian Marron as Chief Executive Officer

Damian was previously CEO at Trophos SA.
News

Trophos Appoints Christine Placet as Chief Executive Officer

Christine becomes CEO under a succession plan designed to provide continuity for Trophos.
News

4SC AG Announces Election of Dr Thomas Werner to Chairman of the Supervisory Board

Company also elected Dr Manfred Rüdiger as its new deputy chairman.
News

Almac Introduces QP Facilitation Programme for Conducting Trials in the European Union

Programme vastly simplifies and expedites the QP release process.
News

Astex Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor

Janssen has received approval to commence a Phase I study of FGFR kinase inhibitor.
News

Adocia Announces a Strengthened Intellectual Property on its Lead Project for its Chronic Wounds Treatment

USPTO and EPO have issued a patent to Adocia covering BioChaperone PDGF formulations for chronic wound treatment.
News

Oncolytics Announces Publication of Translational Clinical Trial Results in Science Translational Medicine

Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients.
News

UBICHEM Group Adds New Large Scale Manufacturing Site

New manufacturing site expands UBICHEM Group’s presence in the non-pharma sector.
Advertisement